Physician
Institute for Rheumatology & Integrative Medicine
Institute for Rheumatology & Integrative Medicine was paid $579K by Medicaid between Jan 2018 and Nov 2024, across 17 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoINSTITUTE FOR RHEUMATOLOGY & INTEGRATIVE MEDICINE
PEMBROKE PINES, FL 33027
PEMBROKE PINES, FL 33027
33aNPI1457442451assigned 09/27/2006
33bProvider typeRheumatology Physician
28Total paid$579K
24GClaims12,072
24DCodes billed17
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Rheumatology Physician providers in Florida
Rank by total paid#6 of 55
Median peer was paid$43K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,202 | $24K | |
| 2019 | 3,485 | $258K | |
| 2020 | 1,925 | $90K | |
| 2021 | 1,671 | $132K | |
| 2022 | 1,432 | $45K | |
| 2023 | 1,328 | $13K | |
| 2024incomplete | 1,029 | $17K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 627 | 450 | $154K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 25% | 1,302 | 916 | $145K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 2,257 | 1,728 | $89K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 14% | 177 | 115 | $83K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 13% | 1,869 | 1,329 | $77K |
| J3262 | Injection, tocilizumab, 1 mg | 2.4% | 57 | 38 | $14K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1.8% | 18 | 12 | $10K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 14 | 12 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,747 | 1,234 | $1K |
| 20610 | <1% | 372 | 175 | $1K | |
| 96401 | <1% | 647 | 236 | $707.61 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,798 | 1,245 | $591.46 |
5 more codes
| 96367 | <1% | 732 | $503.62 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 72 | $104.75 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 39 | $94.51 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 270 | $28.16 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 74 | $26.34 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAM, ALEX (OWNER)